Cargando…
Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients
BACKGROUND: By the use of PSMA positron emission tomography (PET) detection of prostate cancer lesions with a high sensitivity and specificity combined with a favorable lesion to background contrast is feasible. Therefore, PSMA-PET is increasingly used for planning of radiotherapy treatment; however...
Autores principales: | Zschaeck, Sebastian, Wust, Peter, Beck, Marcus, Wlodarczyk, Waldemar, Kaul, David, Rogasch, Julian, Budach, Volker, Furth, Christian, Ghadjar, Pirus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568206/ https://www.ncbi.nlm.nih.gov/pubmed/28830532 http://dx.doi.org/10.1186/s13014-017-0877-x |
Ejemplares similares
-
PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study
por: Rogasch, Julian, et al.
Publicado: (2021) -
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018) -
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017) -
Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy
por: Beck, Marcus, et al.
Publicado: (2017) -
Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients
por: Zschaeck, Sebastian, et al.
Publicado: (2022)